{
    "clinical_study": {
        "@rank": "43573", 
        "arm_group": {
            "arm_group_label": "Combined afib ablation and RA denervation", 
            "arm_group_type": "Experimental", 
            "description": "Patients with atrial fibrillation and resistant hypertension will be enrolled and undergo a single procedure consisting of pulmonary vein isolation and renal artery denervation."
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to perform renal artery denervation at the same time as atrial\n      fibrillation ablation. RA denervation may reduce blood pressure, increase the chances of a\n      successful atrial fibrillation ablation, and decrease the number of medications required to\n      control blood pressure."
        }, 
        "brief_title": "Combined Afib Ablation and RA Denervation for the Maintenance of Sinus Rhythm and Management of Resistant Hypertension", 
        "completion_date": {
            "#text": "January 2019", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Afib", 
            "Hypertension"
        ], 
        "condition_browse": {
            "mesh_term": "Hypertension"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Hypertensive patients scheduled for afib ablation\n\n          -  Patient taking one or more BP medication\n\n        Exclusion Criteria:\n\n        -"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01952925", 
            "org_study_id": "RA-D-9699"
        }, 
        "intervention": {
            "arm_group_label": "Combined afib ablation and RA denervation", 
            "description": "RA denervation performed as part of afib ablation procedure", 
            "intervention_name": "Renal Artery denervation", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 27, 2013", 
        "location": {
            "contact": {
                "email": "henrikso@ohsu.edu", 
                "last_name": "Charles Henrikson, MD", 
                "phone": "503-494-8750"
            }, 
            "facility": {
                "address": {
                    "city": "Portland", 
                    "country": "United States", 
                    "state": "Oregon", 
                    "zip": "97239"
                }, 
                "name": "Oregon Health & Science University"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Combined Atrial Fibrillation Ablation and Renal Artery Denervation for the Maintenance of Sinus Rhythm and Management of Resistant Hypertension", 
        "overall_contact": {
            "email": "henrikso@ohsu.edu", 
            "last_name": "Charles Henrikson, MD", 
            "phone": "503-494-8750"
        }, 
        "overall_official": {
            "affiliation": "Oregon Health and Science University", 
            "last_name": "Charles Henrikson, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "change in systolic blood pressure when measured at routine 1 and 3 month follow up appointments", 
            "safety_issue": "No", 
            "time_frame": "1 to 3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01952925"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Oregon Health and Science University", 
            "investigator_full_name": "Charles Henrikson, MD", 
            "investigator_title": "Associate Professor, Knight Cardiovascular Institute", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Oregon Health and Science University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Oregon Health and Science University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}